The U.S. Food and Drug Administration announced earlier this month that it will be phasing out animal testing for some new ...

Simulations Plus leverages AI-driven tools to revolutionize drug discovery, cut R&D costs, and capitalize on FDA regulatory ...

the U.S. Food and Drug Administration (USFDA) has announced plans to phase out its long-standing requirement for animal testing in the development of monoclonal antibody therapies and other drugs. The ...

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here In an unexpected move, the US Food ...

Congress passed the FDA Modernization Act 2.0 in September 2022, which amended the 1938 law that gave the FDA its regulatory powers to allow for preclinical drug testing to include “non-animal ...

The bill amended the Federal Food, Drug, and Cosmetic Act to remove a requirement that sponsors of new drugs use animal studies to get licensure from the agency, allowing them to use animal ...

The bill amended the Federal Food, Drug, and Cosmetic Act to remove a requirement that sponsors of new drugs use animal studies to get licensure from the agency, allowing them to use animal testing ...

The FDA will begin replacing animal testing in the development of monoclonal antibody therapies and other drugs with human-based methods. The agency said the new approach will aim to improve drug ...